Subjective and objective assessments in patients with seasonal allergic rhinitis: effects of therapy with mometasone furoate nasal spray. (Q47784411)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9679846%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

title

Subjective and objective assessments in patients with seasonal allergic rhinitis: effects of therapy with mometasone furoate nasal spray (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9679846%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

1 reference

seasonal allergic rhinitis

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9679846%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

author name string

E O Meltzer

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9679846%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

A A Jalowayski

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9679846%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

H A Orgel

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9679846%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

language of work or name

English

0 references

publication date

1 July 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9679846%20AND%20SRC:MED&resulttype=core&format=json

The Journal of Allergy and Clinical Immunology

13 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9679846%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

volume

102

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9679846%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9679846%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

page(s)

39-49

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9679846%20AND%20SRC:MED&resulttype=core&format=json

The rationale for use of topical corticosteroids in allergic rhinitis

13 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970053-3

7 January 2021

Allergic rhinitis and inflammation: the effect of nasal corticosteroid therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970053-3

7 January 2021

Nasal cytology in patients with allergic rhinitis: effects of intranasal fluticasone propionate

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970053-3

7 January 2021

The effect of fluticasone propionate aqueous nasal spray on eosinophils and cytokines in nasal secretions of patients with ragweed allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970053-3

7 January 2021

Cytokine immunoreactivity in seasonal rhinitis: regulation by a topical corticosteroid

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970053-3

7 January 2021

Immunologic effects of intranasal corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970053-3

7 January 2021

Pathogenesis of allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970053-3

7 January 2021

Pathophysiology of perennial allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970053-3

7 January 2021

Tryptase and histamine as markers to evaluate mast cell activation during the responses to nasal challenge with allergen, cold, dry air, and hyperosmolar solutions

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970053-3

7 January 2021

Once-daily mometasone furoate nasal spray: efficacy and safety of a new intranasal glucocorticoid for allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970053-3

7 January 2021

A placebo- and active-controlled randomized trial of prophylactic treatment of seasonal allergic rhinitis with mometasone furoate aqueous nasal spray

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970053-3

7 January 2021

Once daily mometasone furoate aqueous nasal spray is as effective as twice daily beclomethasone dipropionate for treating perennial allergic rhinitis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970053-3

7 January 2021

Comparison of once daily mometasone furoate (Nasonex) and fluticasone propionate aqueous nasal sprays for the treatment of perennial rhinitis. 194-079 Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970053-3

7 January 2021

Dose ranging study of mometasone furoate (Nasonex) in seasonal allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970053-3

7 January 2021

Nasal Clearance in Monozygotic Twins1–3

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970053-3

7 January 2021

Evaluation of olfactory dysfunction in the Connecticut Chemosensory Clinical Research Center.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970053-3

7 January 2021

Fluticasone propionate aqueous nasal spray compared with terfenadine tablets in the treatment of seasonal allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970053-3

7 January 2021

Double-strength beclomethasone dipropionate (84 micrograms/spray) aqueous nasal spray in the treatment of seasonal allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970053-3

7 January 2021

Budesonide powder administration for the treatment of grass-pollen-induced allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970053-3

7 January 2021

Multicentric study of beclomethasone dipropionate nasal aerosol in adults with seasonal allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970053-3

7 January 2021

Clinical, rhinomanometric, and cytologic evaluation of seasonal allergic rhinitis treated with beclomethasone dipropionate as aqueous nasal spray or pressurized aerosol

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970053-3

7 January 2021

Concept of true and perceived placebo effects

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970053-3

7 January 2021

Placebo effect in double-blind clinical trials: a review of interactions with medications

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970053-3

7 January 2021

The epidemiologic relationship of clinical nasal allergy to eosinophils and to goblet cells in the nasal smear

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970053-3

7 January 2021

Symptoms of Chronic and Allergic Rhinitis and Occurrence of Nasal Secretion Granulocytes in University Students, School Children and Infants

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970053-3

7 January 2021

The cellular response of the human allergic mucosa to natural allergen exposure

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970053-3

7 January 2021

Activation of guinea pig lymphocytes and mast cells by grain-dust extract

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970053-3

7 January 2021

Interleukin-5 and eosinophil cationic protein in nasal lavages of rhinitis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970053-3

7 January 2021

Topical glucocorticoids inhibit activation by allergen in the upper respiratory tract.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970053-3

7 January 2021

Effect of short-term treatment with fluticasone propionate nasal spray on the response to nasal allergen challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970053-3

7 January 2021

Mast cells and mediators in the nasal mucosa after allergen challenge. Effects of four weeks' treatment with topical glucocorticoid

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970053-3

7 January 2021

Allergen challenge-induced entry of alpha 2-macroglobulin and tryptase into human nasal and bronchial airways

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970053-3

7 January 2021

Monitoring nasal allergic inflammation by measuring the concentration of eosinophil cationic protein and eosinophils in nasal secretions

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970053-3

7 January 2021

The influx of inflammatory cells into nasal washings during the late response to antigen challenge. Effect of systemic steroid pretreatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970053-3

7 January 2021

Inhibition of mediator release in allergic rhinitis by pretreatment with topical glucocorticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970053-3

7 January 2021

Correlation between symptoms and the threshold for release of mediators in nasal secretions during nasal challenge with grass-pollen grains

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970053-3

7 January 2021

Effects of dexamethasone on mediator release from human lung fragments and purified human lung mast cells

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970053-3

7 January 2021

Effect of terfenadine and budesonide on nasal symptoms, olfaction, and nasal airway patency following allergen challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970053-3

7 January 2021

Nasal mucociliary clearance and ciliary beat frequency in cystic fibrosis compared with sinusitis and bronchiectasis

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970053-3

7 January 2021

A nose clinic: initial results

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970053-3

7 January 2021

Hyposmia in allergic rhinitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970053-3

7 January 2021

Relation of olfactory acuity to nasal membrane function

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970053-3

7 January 2021

Olfactory dysfunction in allergic rhinitis is related to nasal eosinophilic inflammation.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970053-3

7 January 2021

10.1016/S0091-6749(98)70053-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9679846%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

1 reference